Current and preclinical treatment options for Merkel cell carcinoma.

Büke CelikdemirRoland HoubenThibault KervarrecMahtab SamimiDavid Schrama

Published in: Expert opinion on biological therapy (2023)

Currently, the only evidence-based therapy for MCC is immune checkpoint blockade with anti-PD-1/PD-L1 for advanced patients. Neoadjuvant, adjuvant and combined immune checkpoint blockade are promising treatment options.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
early stage
lymph node
peritoneal dialysis
prognostic factors
rectal cancer
squamous cell carcinoma
stem cells
radiation therapy
patient reported